The Court of Justice of the European Union has dismissed appeals by Danish company Lundbeck and several pharmaceutical companies against a September 2016 EU General Court ruling that found a cartel dating back to 2002 with the intention of delaying the marketing of the generic antidepressant citalopram, in judgments handed down on Thursday 25 March (cases C-586, 588, 591, 601, 611, 614/16 P) (see EUROPE B11616A29).
According to the Court of Justice, the General Court did not make a mistake...